Cargando…
Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
The present study aimed to construct and evaluate a novel experiment-based hypoxia signature to help evaluations of GBM patient status. First, the 426 proteins, which were previously found to be differentially expressed between normal and hypoxia groups in glioblastoma cells with statistical signifi...
Autores principales: | Wen, Ya-Dan, Zhu, Xiao-San, Li, Dong-Jie, Zhao, Qing, Cheng, Quan, Peng, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390460/ https://www.ncbi.nlm.nih.gov/pubmed/34446747 http://dx.doi.org/10.1038/s41598-021-95980-x |
Ejemplares similares
-
A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM
por: Cheng, Quan, et al.
Publicado: (2019) -
Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
por: Zhang, Wenshuo, et al.
Publicado: (2022) -
Cluster and Principal Component Analysis of Human Glioblastoma Multiforme (GBM) Tumor Proteome
por: Pooladi, Mehdi, et al.
Publicado: (2014) -
Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)
por: Demeure, Kevin, et al.
Publicado: (2016) -
Mitochondrial DNA Alterations in Glioblastoma (GBM)
por: Leão Barros, Mariceli Baia, et al.
Publicado: (2021)